CNR1 and obesity due to melanocortin 4 receptor deficiency: At 48 months after birth, NB1 and CB1 policies are the most efficient scenarios for both overweight and obesity, with estimated costs of €6.4 and €27.6 billion, respectively, for NB1 and €4.7 and €15.0 billion, respectively, for CB1.